Metrics, baseline scores, and a tool to improve sponsor performance on clinical trial diversity: retrospective cross sectional study
Objective To develop a measure for fair inclusion in pivotal trials by assessing transparency and representation of enrolled women, older adults (aged 65 years and older), and racially and ethnically minoritized patients. Design Retrospective cross sectional study. Population Sponsors of novel oncol...
Uloženo v:
Hlavní autoři: | Tanvee Varma, Michelle M. Mello, Joseph S. Ross, Cary P. Gross, Jennifer Miller |
---|---|
Médium: | Artigo |
Jazyk: | angličtina |
Vydáno: |
2023
|
On-line přístup: | https://doi.org/10.1136/bmjmed-2022-000395 https://bmjmedicine.bmj.com/content/bmjmed/2/1/e000395.full.pdf |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Podobné jednotky
-
Promoting Transparency in Pharmaceutical Industry–Sponsored Research
Autor: Ross, Joseph S., a další
Vydáno: (2012) -
Promoting Transparency in Pharmaceutical Industry–Sponsored Research
Autor: Joseph S. Ross, a další
Vydáno: (2011) -
Metrics Survey of Industry-Sponsored Clinical Trials in Canada and Comparator Jurisdictions between 2005 and 2010
Autor: Leclerc, Jean-Marie, a další
Vydáno: (2012) -
Sponsors
Vydáno: (2007) -
Prognostic value of metabolic metrics extracted from baseline PET images in NSCLC
Autor: Carvalho, Sara, a další
Vydáno: (2013)